BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 27389058)

  • 1. Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.
    Pizzi M; Boi M; Bertoni F; Inghirami G
    Leukemia; 2016 Sep; 30(9):1805-15. PubMed ID: 27389058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphomas and Their Microenvironment: A Multifaceted Relationship.
    Menter T; Tzankov A
    Pathobiology; 2019; 86(5-6):225-236. PubMed ID: 31574515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immune microenvironment in malignant lymphoma].
    Nishikori M
    Rinsho Ketsueki; 2019; 60(9):1229-1235. PubMed ID: 31597848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of tumor escape from immune system: role of mesenchymal stromal cells.
    Poggi A; Musso A; Dapino I; Zocchi MR
    Immunol Lett; 2014; 159(1-2):55-72. PubMed ID: 24657523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic alterations underlying immune privilege in malignant lymphomas.
    Mottok A; Steidl C
    Curr Opin Hematol; 2015 Jul; 22(4):343-54. PubMed ID: 26049756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard therapies versus novel therapies in Hodgkin lymphoma.
    Gallamini A; Di Raimondo F; La Nasa G; Romano A; Borra A; Greco M
    Immunol Lett; 2013; 155(1-2):56-9. PubMed ID: 24140162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do tumor stem cells actively escape from host immunosurveillance?
    Qi Y; Li RM; Kong FM; Li H; Yu JP; Ren XB
    Biochem Biophys Res Commun; 2012 Apr; 420(4):699-703. PubMed ID: 22465008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Tumor Microenvironment of Leukemia and Lymphoma.
    Höpken UE; Rehm A
    Trends Cancer; 2019 Jun; 5(6):351-364. PubMed ID: 31208697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathogenesis of lymphoma: focus on CCR4.
    Ishida T; Ueda R
    Cancer Sci; 2011 Jan; 102(1):44-50. PubMed ID: 21044233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricks tumors use to escape from immune control.
    Whiteside TL
    Oral Oncol; 2009 Oct; 45(10):e119-23. PubMed ID: 19467917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microenvironmental abnormalities induced by viral cooperation: Impact on lymphomagenesis.
    De Paoli P; Carbone A
    Semin Cancer Biol; 2015 Oct; 34():70-80. PubMed ID: 25837157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory B cells in anti-tumor immunity.
    Zhang Y; Gallastegui N; Rosenblatt JD
    Int Immunol; 2015 Oct; 27(10):521-30. PubMed ID: 25999597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microenvironment abnormalities and lymphomagenesis: Immunological aspects.
    Taylor JG; Gribben JG
    Semin Cancer Biol; 2015 Oct; 34():36-45. PubMed ID: 26232774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoma Microenvironment and Immunotherapy.
    Xu ML; Fedoriw Y
    Surg Pathol Clin; 2016 Mar; 9(1):93-100. PubMed ID: 26940270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of the microenvironment in B-cell lymphomas.
    Coupland SE
    Histopathology; 2011 Jan; 58(1):69-80. PubMed ID: 21261684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphomagenesis in Hodgkin lymphoma.
    Matsuki E; Younes A
    Semin Cancer Biol; 2015 Oct; 34():14-21. PubMed ID: 25725205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of tumor escape from the immune system: adenosine-producing Treg, exosomes and tumor-associated TLRs.
    Whiteside TL; Mandapathil M; Szczepanski M; Szajnik M
    Bull Cancer; 2011 Feb; 98(2):E25-31. PubMed ID: 21339097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication.
    Burugu S; Asleh-Aburaya K; Nielsen TO
    Breast Cancer; 2017 Jan; 24(1):3-15. PubMed ID: 27138387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component.
    Liu Y; Sattarzadeh A; Diepstra A; Visser L; van den Berg A
    Semin Cancer Biol; 2014 Feb; 24():15-22. PubMed ID: 23867303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.